Regemat 3D - A Groundbreaking Bioprinter

The company introduction of Regemat 3D begins with "Regemat3D develops bioprinters and bioreactors that allow researchers to print cartilage, meniscus, muscle tissue and spinal cord, with the ultimate aim of improving patients quality of life."

In fact, I didn't understand all of this sentence, but I understood a keyword called "Spinal", which is called "spine" in Chinese, so Spinal Cord is also reasonably translated into Jisui, which can print the company of spinal cord, is a rare company in the world.

Let us also start from the four points of investing in new innovations, and look at the Regemat 3D, a cross-generational bioprinter:

1. Pain points:

Let me translate what was mentioned at the beginning: "Regemat3D develops bioprinters and bioreactors that enable researchers to print cartilage, meniscus, muscle tissue and spinal cord", if the human body can be replicated, no matter what way it is, it is absolutely necessary in rigid needs.

2. Solution：

Regemat3D's solution is simple, providing bioprinters, bioreactors, bioinks and peripherals to research institutes and clinics.

3. Entry Barriers：

a. Regemat 3D indicates that there are no relevant competitors in terms of bioreactors (this is a general livelihood type of entrepreneurship, I would not believe this statement, but in this segment of Deep Tech entrepreneurship, this kind of thing may indeed happen, The most obvious example is the previous Intel, they are a monopoly in the IC industry, far ahead of other competitors)

b. Competitive thresholds for sales:

- Customers in 29 countries

- REG4Life bioprinter, which will be the company's Cash Cow

- BMAP Keen (some kind of artificial knee that feels great), coming in 2022

- The previous equity crowdfunding raised £450,000

4. Team：

- CEO - José Manuel Baena Serial entrepreneur, the previous company is also doing biological 3D printing, with a total of more than 10 years of experience in the field of biological 3D printing

- COO - Manuel Figueruela García Linkedin actually wrote in Spanish. I had to copy what he wrote to Google Translate. It seems that I have been a commercial director and a senior marketing officer, and I can really be an operating chief.

Overall, Regemat 3D is a very strong start-up company with a strong team, strong products and strong technology, and there is one thing I almost forgot, that they are expected to go public next year, which means investing money now , it can be redeemed soon, and if you don’t invest now, you can only buy stocks in the public market, and you won’t be able to enjoy the dividends of new startups.

Overall, I give Regemat 3D 4.5 stars, and listed it as a must-invest company. How many stars do you think they should be?

The following is the fundraising link for Regemat 3D, remember to invest a little money:

https://pse.is/46x2ml